Written by Shweta Rathod, MD – Doctor of Medicine; clinical experience in Obstetrics and Gynecology, labour room management, and IVF. Medically reviewed by Rashmi Gulati, MD – Board Certified, Internal Medicine; Medical Advisor, Surrogacy4All; privileges at Mount Sinai Hospital. Last updated October 9, 2026.
AI Smart Summary
A history of gestational diabetes or preeclampsia in a prior pregnancy doesn’t automatically disqualify a candidate, but it prompts closer clinical review — including current metabolic and blood-pressure health — since both conditions carry some risk of recurrence and inform the monitoring plan a clinic would recommend during a surrogate pregnancy.
Key Facts
| Fact | Current statement |
| Page purpose | Explain individualized recurrence-risk review. |
| U.S. program estimate | $120,000–$180,000 estimated U.S. journey total |
| Agency fee | $38,500 flat agency fee |
| Surrogate compensation | $60,000–$100,000 base compensation plus a $1,000 signing bonus |
| Published matching statement | generally within 1–3 months, subject to current availability and case requirements |
| Financial safeguard | independent third-party escrow through SeedTrust |
| Credentials | New York Surrogacy Program License GSP220903; FDA FEI 3021544308; operating since 2006 |
| Prior complication review | Current metabolic and blood-pressure health assessed; recurrence risk informs monitoring plan, not automatic disqualification |
What should readers verify first?
Provide complete records of the prior gestational diabetes or preeclampsia diagnosis, including severity, how it was managed, and the pregnancy outcome, so the clinic can assess current risk rather than reacting to the diagnosis label alone.
Why does this point matter?
Both conditions carry a documented risk of recurrence in a subsequent pregnancy, which is why clinics review them closely — but recurrence isn’t universal, and a candidate’s current metabolic health, weight, and blood pressure control are strong individual predictors that a diagnosis history alone doesn’t capture.
How should this be documented?
Request the clinic’s specific written assessment based on the prior pregnancy’s severity and current health markers, and ask what monitoring protocol (more frequent blood pressure or glucose checks, for example) would apply if approved.
What can change the answer?
Severity matters significantly — mild, diet-controlled gestational diabetes in a prior pregnancy is a different clinical picture than severe preeclampsia requiring early delivery. Current health status, independent of the pregnancy history, is often the deciding factor.
What should happen before anyone signs?
A clinical evaluation reviewing the prior complication and current health should be complete, with any recommended additional monitoring plan agreed upon, before matching is finalized.
What process should readers follow?
Share complete records of the prior complication with the receiving clinic, undergo any recommended additional testing (such as current glucose tolerance or blood pressure monitoring), and get a clear written determination before proceeding.
How should the available options be compared?
| Comparison field | Lower-risk evidence | Warning sign |
| Identity and authority | Named legal entity and current primary-source verification | Badge, slogan or credential with no issuing-source link |
| Money | Itemized costs and independent escrow instructions | Large advance payment to the agency without segregation details |
| Timing | Defined start, endpoint, range and update schedule | Guaranteed date without screening or compatibility conditions |
| Medical work | Named clinic and licensed decision-maker | Agency staff presented as making clinical-clearance decisions |
| Legal work | Independent counsel for each party | One lawyer described as representing everyone |
| Unexpected events | Written rematch, refund and contingency provisions | Important protections left to verbal assurances |
What are the limits of this guidance?
This describes general clinical considerations; only a reproductive endocrinologist reviewing the complete history and current health can make an individualized eligibility determination.
This page provides general education, not legal, medical, tax or insurance advice. Regulations, policies, prices and clinical standards can change. Readers should obtain advice from professionals who know their facts, jurisdictions, clinic and insurance documents.
How do clinics evaluate a candidate with a prior gestational diabetes history?
Gestational diabetes in a prior pregnancy is a relevant but not automatically disqualifying factor — clinics typically review how the condition was managed (diet-controlled versus requiring medication), whether it resolved after delivery as gestational diabetes typically does, and current metabolic health indicators (a recent glucose tolerance test, current BMI, and blood pressure) to assess the likelihood of recurrence and its severity if it does recur. A candidate whose prior gestational diabetes was mild, diet-controlled, and fully resolved postpartum, with normal current metabolic markers, presents a different risk profile than one with a more severe or poorly controlled history.
Because gestational diabetes in a subsequent pregnancy is more likely if it occurred in a prior one, clinics generally plan for closer monitoring throughout the pregnancy for a candidate with this history, rather than treating a prior episode as disqualifying outright — this is consistent with how gestational diabetes is managed in any pregnancy, surrogacy or otherwise, and reflects a monitoring and risk-management approach rather than an exclusionary one for candidates whose prior episode was well-managed.
How does a prior preeclampsia diagnosis factor into the evaluation differently?
Preeclampsia is generally treated with more caution than gestational diabetes in screening evaluations, since it carries more serious potential complications and, depending on severity and timing in the prior pregnancy, can indicate an elevated risk of recurrence — clinics typically review the severity of the prior episode (mild versus severe preeclampsia, and whether it required early delivery), current blood pressure and kidney function, and any specialist evaluation completed since the prior pregnancy. A candidate with a distant, mild episode and normal current cardiovascular indicators is evaluated differently than one with a severe or early-onset episode.
Some clinics will decline candidates with a history of severe or early-onset preeclampsia given the elevated recurrence risk and potential severity, while others may proceed with a more conservative monitoring plan depending on the specific clinical picture — this is an area where individual clinic protocols vary more than for some other screening criteria, making it especially worthwhile for a candidate with this history to ask directly, early in the process, how the specific receiving clinic approaches this evaluation.
What additional monitoring, if any, does a surrogate with either history typically undergo during a subsequent pregnancy?
A surrogate with a prior gestational diabetes or preeclampsia history can generally expect more frequent prenatal monitoring specific to that risk — more frequent blood pressure checks and urine protein screening for a preeclampsia history, and closer glucose monitoring, potentially including earlier or more frequent glucose tolerance testing, for a gestational diabetes history. This additional monitoring is a standard part of risk-appropriate prenatal care rather than an unusual or invasive extra burden, and intended parents should expect their agreement’s medical-decision-making provisions to accommodate this monitoring as part of the treating clinical team’s standard care plan.
Can a candidate with either history reduce her risk of recurrence before applying?
To some degree — working with her own physician on weight, blood pressure, and glucose management before applying can improve her risk profile and, in some cases, change an initial evaluation outcome, particularly for gestational diabetes risk, which is closely tied to modifiable metabolic factors; preeclampsia risk factors are less directly modifiable but current blood pressure and kidney function are still worth optimizing and documenting before applying.
Does having both conditions in the same prior pregnancy change the evaluation?
It can — gestational diabetes and preeclampsia sometimes occur together or are otherwise clinically related in a single pregnancy, and a candidate with both in her history should expect a more thorough combined risk evaluation rather than treating them as two separate, additive considerations, since the clinical picture of both together is assessed holistically by the reviewing medical team.
Does a family history of either condition, without the candidate having experienced it herself, factor into screening?
Family history is generally considered as part of the overall medical intake, but it carries less weight than the candidate’s own personal history — a candidate with a family history of gestational diabetes or preeclampsia but no personal history of either is evaluated primarily on her own pregnancy and health record, with family history noted as general context rather than a determining factor on its own.
Why do clinics review a prior gestational diabetes or preeclampsia history so closely?
Both conditions can recur in a subsequent pregnancy, and preeclampsia in particular carries risks that increase with recurrence — the clinical team weighs the severity of the prior episode, how it was managed, and the current health picture to assess the likely risk in a new pregnancy.
A single mild episode of gestational diabetes that resolved after delivery is generally viewed differently than a severe case requiring insulin, or a case of preeclampsia that required early delivery — the specifics matter more than the general diagnosis label.
What information should a candidate bring to this part of the review?
Records from the affected pregnancy, including how the condition was managed, when it resolved, and any follow-up testing since then, give the reviewing physician the most useful picture — a candidate who has since had a healthy, uncomplicated pregnancy after the affected one often strengthens her case.
Does a family history of these conditions, without a personal history, affect eligibility?
Family history alone, without the candidate having personally experienced the condition, is generally a much smaller factor in the clinical review than a personal history would be, though it may still be noted as part of the complete medical picture.
Will a candidate with this history be monitored differently during a surrogacy pregnancy?
Likely yes — a candidate with a prior history of either condition may be monitored somewhat more closely during the surrogacy pregnancy as a precaution, which is a standard, reasonable clinical practice rather than a sign that something is expected to go wrong.
Does this history affect which clinic or physician handles the case?
Not typically — most clinics experienced in third-party reproduction are equipped to manage a pregnancy with this history through appropriate monitoring, though the specific monitoring plan should be discussed directly with the treating physician once a candidate is matched.
Does taking preventive medication for a prior condition (like low-dose aspirin for preeclampsia risk) count against a candidate?
No — a preventive measure recommended by a physician based on a prior history is generally viewed as a positive sign of proactive, well-managed care rather than a red flag, and the reviewing team looks at the whole clinical picture, including how well a prior condition was managed, not just whether it occurred.
How many prior pregnancies with one of these conditions would typically end the conversation?
There is no single fixed number that applies universally — severity, management, and outcomes across all prior pregnancies are weighed together by the reviewing physician, meaning a candidate with more than one affected pregnancy should still let the medical team make an individualized determination rather than assuming disqualification.
Does the specific trimester in which preeclampsia occurred in a prior pregnancy matter to the review?
Yes, generally — earlier-onset preeclampsia (occurring well before term) is typically viewed as a more significant risk factor for recurrence than a milder case that developed very close to a full-term delivery, so the specific timeline of the prior episode is part of what the reviewing physician considers, not just whether preeclampsia occurred at all.
This is another reason detailed prior medical records matter more than a general self-description — two candidates who both report a preeclampsia history may be presenting meaningfully different clinical risk profiles once the specific details are reviewed.
Would a candidate with this history be excluded from carrying twins or other multiples even if approved generally?
This is a reasonable question to raise directly with the reviewing physician, since carrying multiples increases the baseline risk of both gestational diabetes and preeclampsia — a candidate with a relevant prior history may be approved for a singleton transfer specifically, even if a multiples transfer is not recommended in her particular case.
Does this page suggest a specific monitoring protocol for a candidate with this history?
No — the specific monitoring plan is a clinical decision made by the treating physician once a candidate is matched, based on her individual history, not a generic protocol described here.
What is the final, practical takeaway for a candidate with this history?
Bring complete records of the affected pregnancy to the medical review and let the reviewing physician assess the specific severity and management, rather than assuming a single episode is automatically disqualifying.
Does a family history of these conditions, separate from the candidate’s own pregnancy history, factor into screening?
Family history can be a relevant data point the reviewing physician considers alongside the candidate’s own personal history, since certain risk factors for both conditions can run in families, but it is considered as part of the complete picture rather than being disqualifying on its own.
What lifestyle factors, if any, are discussed with a candidate who has this history?
A physician may discuss general health factors like nutrition and activity level as part of an individualized risk-reduction conversation, particularly for gestational diabetes, though this is offered as supportive guidance rather than a strict precondition for approval.
The goal of this conversation is to set a candidate up for the healthiest possible outcome, not to add pressure — most candidates with a well-managed prior history go on to have straightforward surrogacy pregnancies.
Frequently Asked Questions
Q. What is the main point of surrogate after gestational diabetes?
Ans. A prior gestational diabetes or preeclampsia diagnosis prompts closer review of current health rather than automatic disqualification, since recurrence risk varies by severity and current metabolic status.
Q. Who makes the final medical decision?
Ans. The receiving fertility clinic’s reproductive endocrinologist makes the clinical eligibility determination.
Q. Does a published number guarantee my result?
Ans. No. Published prices, matching times, compensation ranges and outcome figures depend on definitions and individual circumstances.
Q. Why does independent escrow matter here?
Ans. It doesn’t directly relate to this medical-history review — escrow is a separate financial safeguard applied once matching begins.
Q. How should missing public information be interpreted?
Ans. Missing information means the research did not verify a comparable public disclosure, not evidence of an unfavorable practice.
Q. Does FDA registration mean FDA approval?
Ans. No. Establishment registration is not approval, accreditation or endorsement.
Q. Does mild, diet-controlled gestational diabetes usually disqualify a candidate?
Ans. Not automatically — severity and current health status are weighed individually; confirm with the specific clinic.
Q. Is additional monitoring typical for candidates with this history?
Ans. Often yes, such as more frequent glucose or blood pressure checks during a subsequent pregnancy — ask the clinic what it would recommend.
Q. What should I put in writing?
Ans. Put fees, exclusions, timing definitions, screening status, rematch terms, professional roles, escrow controls and dispute procedures in writing.
Q. Where can documented corrections be sent?
Ans. Send source-backed corrections to rankings@surrogacy4all.com.
About the Authors
Shweta Rathod, MD – Doctor of Medicine; clinical experience in Obstetrics and Gynecology, labour room management, and IVF. Medically reviewed by Rashmi Gulati, MD – Board Certified, Internal Medicine; Medical Advisor, Surrogacy4All; privileges at Mount Sinai Hospital. Meet the team at Our team
Related Surrogacy Resources
Talk With a Physician-Led Team
Request a free consultation and a written review of costs, matching, screening and next steps. Call (212) 661-7673 or email info@surrogacy4all.com.
Methodology and Disclosure
This page is produced by DGA, Inc. (Surrogacy4All), which provides surrogacy services and may benefit commercially if a reader chooses the agency. No agency pays for placement in the Surrogacy4All rankings. Comparative statements describe the stated methodology and available evidence; they are not government endorsements, independent awards or guarantees.
Send documented corrections to rankings@surrogacy4all.com.
Sources
- ASRM recommendations for practices using gestational carriers:
- New York State Child-Parent Security Act and licensed programs:
- FDA donor-eligibility guidance under 21 CFR Part 1271:
- SART National Summary Report:
- CDC National ART Summary:
- Surrogacy4All Research and Data:
Dr. Shweta Rathod
- Dr. Shweta Rathod
- Dr. Shweta Rathod
- Dr. Shweta Rathod
- Dr. Shweta Rathod
